Curaleaf's Boris Jordan on CBD regulation and second-quarter earnings

0 20



Curaleaf executive chairman Boris Jordan discusses the company’s second quarter results as well as CBD regulation from the FDA with CNBC’s “Squawk on the …

source

Leave A Reply

Your email address will not be published.